α -2肾上腺素能受体激动剂治疗创伤性脑损伤后遗症。

IF 3.3 3区医学 Q2 CLINICAL NEUROLOGY

Journal of Head Trauma Rehabilitation Pub Date : 2025-08-22 DOI:10.1097/HTR.0000000000001099

Jamie L Ott, Thomas K Watanabe

{"title":"α -2肾上腺素能受体激动剂治疗创伤性脑损伤后遗症。","authors":"Jamie L Ott, Thomas K Watanabe","doi":"10.1097/HTR.0000000000001099","DOIUrl":null,"url":null,"abstract":"Objective: To describe clinical uses of the class of alpha-2 receptor agonist medications in the treatment of traumatic brain injury sequelae. Clinicians treating patients with traumatic brain injuries (TBI) will often see patients who have been prescribed alpha-2 agonists or may consider initiating use.Design: Narrative review.Conclusion: This class of medication has a number of different indications (and side effects), and drugs within this class also have some unique properties that can be important factors in clinical decision-making. Although this class of medications has been available for many years, there is still much emerging information that is pertinent for the treatment of patients with TBI.","PeriodicalId":15901,"journal":{"name":"Journal of Head Trauma Rehabilitation","volume":" ","pages":""},"PeriodicalIF":3.3000,"publicationDate":"2025-08-22","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":"{\"title\":\"Management of Traumatic Brain Injury Sequelae With Alpha-2 Adrenergic Receptor Agonists.\",\"authors\":\"Jamie L Ott, Thomas K Watanabe\",\"doi\":\"10.1097/HTR.0000000000001099\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"Objective: To describe clinical uses of the class of alpha-2 receptor agonist medications in the treatment of traumatic brain injury sequelae. Clinicians treating patients with traumatic brain injuries (TBI) will often see patients who have been prescribed alpha-2 agonists or may consider initiating use.Design: Narrative review.Conclusion: This class of medication has a number of different indications (and side effects), and drugs within this class also have some unique properties that can be important factors in clinical decision-making. Although this class of medications has been available for many years, there is still much emerging information that is pertinent for the treatment of patients with TBI.\",\"PeriodicalId\":15901,\"journal\":{\"name\":\"Journal of Head Trauma Rehabilitation\",\"volume\":\" \",\"pages\":\"\"},\"PeriodicalIF\":3.3000,\"publicationDate\":\"2025-08-22\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"\",\"citationCount\":\"0\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"Journal of Head Trauma Rehabilitation\",\"FirstCategoryId\":\"3\",\"ListUrlMain\":\"https://doi.org/10.1097/HTR.0000000000001099\",\"RegionNum\":3,\"RegionCategory\":\"医学\",\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"Q2\",\"JCRName\":\"CLINICAL NEUROLOGY\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"Journal of Head Trauma Rehabilitation","FirstCategoryId":"3","ListUrlMain":"https://doi.org/10.1097/HTR.0000000000001099","RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q2","JCRName":"CLINICAL NEUROLOGY","Score":null,"Total":0}

引用次数: 0

摘要

目的：介绍α -2受体激动剂类药物在颅脑外伤后遗症治疗中的临床应用。治疗创伤性脑损伤（TBI）患者的临床医生经常会看到已经开过α -2激动剂或可能考虑开始使用的患者。设计：叙述回顾。结论：这类药物有许多不同的适应症（和副作用），这类药物也有一些独特的性质，可以成为临床决策的重要因素。尽管这类药物已经可用多年，但仍有许多与TBI患者治疗相关的新信息。

本文章由计算机程序翻译，如有差异，请以英文原文为准。

查看原文本刊更多论文

Management of Traumatic Brain Injury Sequelae With Alpha-2 Adrenergic Receptor Agonists.

Objective: To describe clinical uses of the class of alpha-2 receptor agonist medications in the treatment of traumatic brain injury sequelae. Clinicians treating patients with traumatic brain injuries (TBI) will often see patients who have been prescribed alpha-2 agonists or may consider initiating use.

Design: Narrative review.

Conclusion: This class of medication has a number of different indications (and side effects), and drugs within this class also have some unique properties that can be important factors in clinical decision-making. Although this class of medications has been available for many years, there is still much emerging information that is pertinent for the treatment of patients with TBI.

求助全文

通过发布文献求助，成功后即可免费获取论文全文。去求助

来源期刊

Journal of Head Trauma Rehabilitation 医学-康复医学

CiteScore

4.80

自引率

4.20%

发文量

153

审稿时长

6-12 weeks

期刊介绍： The Journal of Head Trauma Rehabilitation is a leading, peer-reviewed resource that provides up-to-date information on the clinical management and rehabilitation of persons with traumatic brain injuries. Six issues each year aspire to the vision of “knowledge informing care” and include a wide range of articles, topical issues, commentaries and special features. It is the official journal of the Brain Injury Association of America (BIAA).